These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19179470)

  • 1. C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function.
    Bossi F; Rizzi L; Bulla R; Debeus A; Tripodo C; Picotti P; Betto E; Macor P; Pucillo C; Würzner R; Tedesco F
    Blood; 2009 Apr; 113(15):3640-8. PubMed ID: 19179470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement components C5 and C7: recombinant factor I modules of C7 bind to the C345C domain of C5.
    Thai CT; Ogata RT
    J Immunol; 2004 Oct; 173(7):4547-52. PubMed ID: 15383587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation.
    Kilgore KS; Schmid E; Shanley TP; Flory CM; Maheswari V; Tramontini NL; Cohen H; Ward PA; Friedl HP; Warren JS
    Am J Pathol; 1997 Jun; 150(6):2019-31. PubMed ID: 9176395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant C345C and factor I modules of complement components C5 and C7 inhibit C7 incorporation into the complement membrane attack complex.
    Thai CT; Ogata RT
    J Immunol; 2005 May; 174(10):6227-32. PubMed ID: 15879120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane attack complex formation on yeast as trigger of selective release of terminal complement proteins from human polymorphonuclear leukocytes.
    Lukasser-Vogl E; Gruber A; Lass-Flörl C; Eder A; Høgåsen AK; Morgan BP; Dierich MP; Würzner R
    FEMS Immunol Med Microbiol; 2000 May; 28(1):15-23. PubMed ID: 10767603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane attack complex-associated molecules from redlip mullet (Liza haematocheila): Molecular characterization and transcriptional evidence of C6, C7, C8β, and C9 in innate immunity.
    Liyanage DS; Omeka WKM; Godahewa GI; Lee S; Nam BH; Lee J
    Fish Shellfish Immunol; 2018 Oct; 81():1-9. PubMed ID: 29981471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using polymerized C9 to produce a monoclonal antibody against a neoantigen of the human terminal complement complex.
    Kusunoki Y; Takekoshi Y; Nagasawa S
    J Pharmacobiodyn; 1990 Jul; 13(7):454-60. PubMed ID: 2290128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement C7 and clusterin form a complex in circulation.
    Massri M; Toonen EJM; Sarg B; Kremser L; Grasse M; Fleischer V; Torres-Quesada O; Hengst L; Skjoedt MO; Bayarri-Olmos R; Rosbjerg A; Garred P; Orth-Höller D; Prohászka Z; Würzner R
    Front Immunol; 2024; 15():1330095. PubMed ID: 38333209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and characterization of recombinant human C9 or C7 linked to single chain Fv directed to CD25.
    Raitses Gurevich M; Fishelson Z
    Mol Immunol; 2013 Oct; 55(3-4):400-8. PubMed ID: 23582305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity.
    Tedesco F; Pausa M; Nardon E; Introna M; Mantovani A; Dobrina A
    J Exp Med; 1997 May; 185(9):1619-27. PubMed ID: 9151899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of PPARδ and PPARγ in inhibiting the pro-inflammatory effects of C-reactive protein in endothelial cells.
    Liang YJ; Liu YC; Chen CY; Lai LP; Shyu KG; Juang SJ; Wang BW; Leu JG
    Int J Cardiol; 2010 Sep; 143(3):361-7. PubMed ID: 19395102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis.
    Corallini F; Bossi F; Gonelli A; Tripodo C; Castellino G; Mollnes TE; Tedesco F; Rizzi L; Trotta F; Zauli G; Secchiero P
    Rheumatology (Oxford); 2009 Mar; 48(3):293-8. PubMed ID: 19168833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of SP-40,40 into the soluble membrane attack complex (SMAC, SC5b-9) of complement.
    Choi NH; Nakano Y; Tobe T; Mazda T; Tomita M
    Int Immunol; 1990; 2(5):413-7. PubMed ID: 2150757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial nuclear factor-kappaB translocation and vascular cell adhesion molecule-1 induction by complement: inhibition with anti-human C5 therapy or cGMP analogues.
    Collard CD; Agah A; Reenstra W; Buras J; Stahl GL
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2623-9. PubMed ID: 10559004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The membrane attack complex of complement: relation of C7 to the metastable membrane binding site of the intermediate complex C5b-7.
    Preissner KT; Podack ER; Müller-Eberhard HJ
    J Immunol; 1985 Jul; 135(1):445-51. PubMed ID: 3998468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell activation by pore-forming structures: pivotal role for interleukin-1alpha.
    Saadi S; Holzknecht RA; Patte CP; Platt JL
    Circulation; 2000 Apr; 101(15):1867-73. PubMed ID: 10769290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexes.
    Sawant-Mane S; Clark MB; Koski CL
    Ann Neurol; 1991 Apr; 29(4):397-404. PubMed ID: 1718212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell tryptase in mast cell granules enhances MCP-1 and interleukin-8 production in human endothelial cells.
    Kinoshita M; Okada M; Hara M; Furukawa Y; Matsumori A
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1858-63. PubMed ID: 15976326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-protein/vitronectin interaction with the C5b and the C8 of the complement membrane attack complex.
    Su HR
    Int Arch Allergy Immunol; 1996 Aug; 110(4):314-7. PubMed ID: 8768797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endothelium is an extrahepatic site of synthesis of the seventh component of the complement system.
    Langeggen H; Pausa M; Johnson E; Casarsa C; Tedesco F
    Clin Exp Immunol; 2000 Jul; 121(1):69-76. PubMed ID: 10886241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.